CION Ameerpet
Diagnosis · Reviewed by CION Oncologists · NABH Accredited
PET-CT for Endometrial Cancer — When It Is Actually Needed
Women frequently ask for a PET-CT after a cancer diagnosis, on the entirely reasonable assumption that the most comprehensive scan must be the best one. For endometrial cancer that assumption does not hold. MRI is the standard staging test, because the question that matters most — how deeply the tumour has invaded the muscle of the uterus — is one MRI answers well and PET-CT does not. PET-CT answers a different question: whether disease is present elsewhere in the body. That question is worth asking in specific circumstances and not in most. This page explains which.
- MRI is the pelvic workhorse — depth of invasion is what changes the plan
- PET-CT looks for distant disease — a different question, not a better scan
- Used selectively, for good reasons — false positives cause real harm
- Central in suspected recurrence — this is where it earns its place
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Which Scan Answers Which Question
Each imaging test in endometrial cancer has a job. Understanding which is which makes it clear why more is not better.
| Test | The question it answers |
|---|---|
| Transvaginal ultrasound | The first test. Measures the lining and looks at the cavity, deciding whether a biopsy is needed at all. Quick, available and where nearly every pathway starts. See transvaginal ultrasound. |
| MRI of the pelvis | The staging workhorse. How deeply the tumour invades the muscle of the uterus, whether the cervix is involved, whether disease extends beyond the uterus, and what the pelvic nodes look like. This is the information that shapes the operation. See MRI for endometrial cancer. |
| CT of chest, abdomen and pelvis | Looks for disease outside the pelvis — lungs, liver, abdominal nodes. Widely available and frequently sufficient for that purpose, which is part of why PET-CT is not needed routinely. |
| PET-CT | Whole-body assessment of metabolically active disease. More sensitive than CT for distant spread in higher-risk situations, and the test of choice when recurrence is suspected and needs mapping before treatment is planned. |
| Chest X-ray | A simple check of the lungs, still used in low-risk disease where more extensive imaging is not warranted. |
| The pathology itself | Worth naming alongside the scans, because no imaging test replaces it. Grade, type, mismatch repair and p53 status all come from tissue and drive treatment as much as any scan does. See molecular classification. |
The question “why have I not had a PET-CT?” usually has a good answer. For early-stage disease confined to the uterus, MRI plus either CT or a chest X-ray gives the information needed to plan treatment. Adding PET-CT to that seldom changes the plan and not uncommonly generates a false alarm.
Did You Know? The reason PET-CT is not used routinely in endometrial cancer is not cost — it is that in early-stage disease it changes management rarely and misleads occasionally. PET works by detecting tissue that takes up glucose avidly, and cancer does. Unfortunately so does inflammation, infection, healing tissue and a range of ordinary benign processes. In a woman with early low-grade disease confined to the uterus, the chance that a PET-CT finds genuine distant spread is small, while the chance it lights up something benign is not. Each of those findings then generates further scans, further biopsies and a period of real fear, all for a lesion that was never cancer. Sources: NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms; ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; ESUR guidelines on staging of endometrial cancer.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
When PET-CT Genuinely Helps
Five situations where it earns its place.
- Suspected recurrence. The strongest indication. Where a rise in a marker, a symptom or an equivocal scan raises the possibility of disease returning, PET-CT is well suited to finding where and mapping how much. See detecting recurrence.
- Before treating a recurrence with intent to cure. If salvage surgery or radiotherapy is being considered for what looks like disease in a single site, it matters enormously whether that is truly the only site. This is exactly the question PET-CT is good at.
- High-risk histological subtypes. Serous carcinoma, clear cell carcinoma and carcinosarcoma behave more aggressively and spread outside the pelvis more readily, so a whole-body assessment before planning is more often justified. See clear cell carcinoma.
- Suspicion of distant spread. Where symptoms, examination or another scan suggests disease outside the pelvis, PET-CT clarifies the extent in one study rather than several.
- Equivocal findings elsewhere. Where CT or MRI shows something that cannot be characterised and the answer would change the treatment plan.
Outside these situations, the case for PET-CT weakens considerably — and in early low-grade disease it is generally not indicated. If you want to understand what a PET-CT would cost, that is set out separately. See PET-CT cost.
Want to Know Which Scans You Actually Need?
Existing imaging reviewed by our tumour board before anything new is ordered.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
More Scanning Is Not Better Care
A false positive costs you further tests, further waiting and real fear — for something that was never cancer.
What Having a PET-CT Involves
Longer than an ordinary scan, mostly because of the waiting rather than the scanning.
- Preparation matters more than for other scans. Fasting for several hours beforehand, and avoiding strenuous exercise for a day or two, since active muscle takes up the tracer and can obscure the picture. Follow the instructions exactly — they affect the quality of the result.
- Tell them if you are diabetic. Genuinely important. Blood sugar affects how the tracer distributes, and the appointment and your medication may need arranging differently. Say so when booking rather than on the day. See diabetes and endometrial cancer.
- The tracer is injected, then you wait. A period of quiet rest while it distributes — you will be asked to sit still and not talk much, because active muscle takes it up. This waiting is most of the appointment.
- The scan itself is straightforward. Lying still in a scanner for a period of time. Not enclosed in the way an MRI is, and most women find it easier than they expected.
- The radiation dose is real but proportionate. Higher than a plain X-ray, and justified when the scan will change your treatment. It is one of the reasons the test is used selectively rather than routinely.
Unsure Whether You Need This Scan?
Bring your existing imaging. A review of what has been done and what would actually change the plan. The opinion is free.
Reading a PET-CT Report Sensibly
PET-CT reports contain language that frightens people unnecessarily. Five things worth knowing.
"Uptake" does not mean cancer
The scan detects tissue using glucose actively. Cancer does — and so does infection, inflammation, healing after surgery, arthritis and a good deal of ordinary biology. A report noting uptake somewhere is describing metabolic activity, not making a diagnosis. What matters is the pattern, the location and the context.
A number is not a verdict
PET reports often quote a figure for the intensity of uptake. It is a useful measure and it is not a threshold above which something is cancer and below which it is not. It is one input among several, and it should never be read on its own by a patient or by a clinician.
Small deposits can be missed
PET-CT has limited sensitivity for very small-volume disease, including small lymph node deposits. A clear scan is reassuring and it is not proof that nothing microscopic is present, which is part of why surgical assessment of nodes still matters. See sentinel node biopsy.
The bowel and bladder light up normally
Physiological uptake in the bowel and urinary tract is expected and is a routine source of confusion when patients read their own reports. An experienced reporter accounts for it; a worried reader at midnight does not.
Confirmation is sometimes needed
Where an unexpected finding would change your treatment, a biopsy of that site is often the right next step rather than acting on the scan alone. Being told this is good practice rather than hesitation. See second opinion.
Why Scans Should Be Ordered by a Board, Not a Reflex
The right question is not what can be scanned but what finding would actually change your treatment.
Tumour board for every diagnosis
Slides reviewed, not just the summary line
One place for the whole pathway
Costs explained before you commit
45-minute consultations
Second opinions welcomed, not resented
Take The Next Step
MRI Answers the Question That Shapes Surgery
Depth of invasion is what determines the operation. That is an MRI question, not a PET one.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
PET-CT — Frequently Asked Questions
Why have I not been offered a PET-CT?
Most likely because it would not change your treatment. For endometrial cancer, MRI is the standard staging test, because the question that most affects the operation — how deeply the tumour has invaded the muscle of the uterus, and whether the cervix is involved — is one MRI answers well. CT or a chest X-ray covers whether disease is present outside the pelvis. In early-stage, low-grade disease, adding PET-CT to that seldom alters the plan, while it does carry a real chance of lighting up something benign such as inflammation, which then generates further tests and genuine fear. It is used selectively for that reason, not as rationing.
Is PET-CT better than MRI for endometrial cancer?
They answer different questions, so neither is better in general. MRI shows soft tissue detail in the pelvis and is the test for depth of invasion into the uterine muscle, cervical involvement and local extension — the findings that determine the extent of surgery. PET-CT shows metabolic activity throughout the body and is better at identifying disease at distant sites. If your disease appears confined to the uterus, the MRI questions are the ones that matter. If there is reason to suspect spread beyond the pelvis, or if recurrence is suspected, PET-CT becomes the more useful test.
When is PET-CT definitely worth having?
Most clearly when recurrence is suspected — a symptom, a rising marker or an equivocal scan raising the possibility that disease has returned. It is well suited to finding where and to mapping how much, which matters enormously if salvage surgery or radiotherapy is being considered, since treating one site with intent to cure depends on it genuinely being the only site. It is also more often justified in high-risk histological subtypes such as serous carcinoma, clear cell carcinoma and carcinosarcoma, which spread outside the pelvis more readily, and where symptoms or other imaging suggest distant disease.
My PET-CT report mentions uptake somewhere. Does that mean the cancer has spread?
Not necessarily, and this is the commonest source of unnecessary alarm from these reports. PET detects tissue using glucose actively, which cancer does — but so does infection, inflammation, tissue healing after surgery, arthritis and a range of ordinary processes. Physiological uptake in the bowel and urinary tract is expected and routinely confuses people reading their own reports. What matters is the pattern, the location, and the clinical context, which is why these scans are interpreted by specialists alongside your other findings. Where an unexpected result would change your treatment, a biopsy of that site is often the right next step rather than acting on the scan alone.
Can a normal PET-CT guarantee the cancer has not spread?
No, and it is worth being clear about this. PET-CT has limited sensitivity for very small-volume disease, including small deposits within lymph nodes, which can be present without being visible. A clear scan is genuinely reassuring and it is not proof that nothing microscopic exists. This is one of the reasons surgical assessment of the lymph nodes still has a role at operation, and why the final pathology from the removed uterus and nodes — not the scan — provides the definitive stage on which decisions about treatment after surgery are based.
Medical disclaimer: This page provides general information about PET-CT in endometrial cancer, reviewed by a CION oncologist. It is not a substitute for individual medical advice. Which imaging tests are appropriate depends on your tumour type, grade, apparent stage and clinical circumstances, and should be decided by your treating team. PET-CT findings require specialist interpretation in clinical context and should not be interpreted from the report alone.